NovAccess Global (QB) Stock Price

0.02 (11.11%)
Volume 5,025
Bid Price 0.1548
Ask Price 0.22
News -
Day High 0.20


52 Week Range


Day Low 0.20
Company Name Stock Ticker Symbol Market Type
NovAccess Global Inc (QB) XSNX OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.02 11.11% 0.20 16:00:47
Open Price Low Price High Price Close Price Prev Close
0.20 0.20 0.20 0.20 0.18
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2 5,025 $ 0.20 $ 1,005 - 0.103 - 0.75
Last Trade Time Type Quantity Stock Price Currency
12:38:40 5,000 $ 0.20 USD


Draw Mode:

NovAccess Global Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.71M 18.53M 2.45M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
5.35k $ - - - -

more financials information »

NovAccess Global (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XSNX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.,9540.0317.65%
1 Month0.2210.300.170.189969510,588-0.021-9.5%
3 Months0.270.600.1030.246749111,057-0.07-25.93%
6 Months0.4350.600.1030.26993336,721-0.235-54.02%
1 Year0.52510.750.1030.42449268,356-0.3251-61.91%
3 Years0.00050.970.00020.00220761,297,6300.199539,900.0%
5 Years0.0010.970.00010.00139483,641,6260.19919,900.0%

NovAccess Global (QB) Description

NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through our advisory board we have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecule development and gene therapy as well as other technical assays required for protein and genetic analysis of cancer cells. NovAccess Global is a research and development (R&D) company based in Ohio and California, and our executive management and scientific advisory board have over 15 years of experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. Our performance is guided by our commitment to deliver consistently on the following core objectives: (1) Accountability- taking responsibility for providing safe and effective treatment options for patients; (2) Integrity- doing what is ethically right for the patient; (3) Excellence- doing your best and working hard; and (4) Teamwork- bringing together a strong working team to deliver the best products for brain tumor patients.

Your Recent History
NovAccess ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now